Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Medical
- Device
- Delivery
- Diagnostic
- Catheter
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 26989
License Grant
We entered into a development and license agreement with a privately-owned Swiss company, pursuant to which the Licensor seeks to develop an externally-worn insulin pump using its patented micro electro-mechanical systems (MEMS) technology. We will have the exclusive right to commercialize diabetes products using Licensor's MEMS technology.
Field of Use
The rights granted apply to all of the Intellectual Property for the field consisting of all uses relating to the treatment, diagnosis and prevention of diabetes with the exception of the implantable pump which is the subject of the Implantable Pump Agreement.
IPSCIO Record ID: 1804
License Grant
The Company hereby grants the worldwide right to manufacture, cause to be manufactured, promote, sell, market, distribute and use the Pump Technology; programmable implantable insulin pump system.
License Property
Implantable microinfusion pump systems intended for in vivo use; utilizes Pump Technology for diabetes or non-diabetes applications. Glucose Controllers, Glucose Monitors, Long-Term Glucose Sensors and the abdominal lead that connects the implantable pump to a Long-Term Glucose Sensor are not Licensed Products. An apparatus or system which utilizes Glucose Sensing Technology to control an insulin infusion device in a human or in an animal. Any monitor product utilizing Glucose Sensing Technology to provide indications of glucose concentration or changes in glucose concentration in a human or in an animal.
IPSCIO Record ID: 180208
License Grant
The company entered into an agreement providing the company with exclusive rights in the United States and certain other countries to develop Licensors proprietary intravascular infusion catheter to be used with its SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of pulmonary arterial hypertension (PAH).
License Property
The proprietary intravascular infusion catheter is to be used with its SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of PAH. The Implantable System for Remodulin will be exclusive to Remodulin so long as we purchase a minimum percentage of our annual requirement for implantable pump systems from Licensor.
Field of Use
This agreement pertains to the medical industry.
IPSCIO Record ID: 282814
License Grant
For the Exclusive License, the Swiss Licensor grants an exclusive, even as to Licensor, worldwide license, with the right to sublicense, under all Licensor Intellectual Property, excluding intellectual property jointly developed by Licensor and a third party, and a nonexclusive sub-license under the Seiko License and Licensor Intellectual Property jointly developed by Licensor and a third party, to make, have made, use, sell, offer for sale, or import Licensor Pump System in the Field.
Simultaneously with the execution of this Agreement, the Parties shall enter into a parallel License, Joint Development and Manufacturing Assistance Agreement in connection ·with a micro-needle product of the Licensor.
License Property
The Intellectual property is all patents, copyrights, trade secrets, know-how and other intellectual property related to or useful to an externally-worn micro-pump utilizing MEMS technology owned by, developed by or licensed to Licensor.
Licensors Pump is an externally worn micro-pump system for the delivery of insulin incorporating a MEMS Chip and based upon Licensor Intellectual Property. In its initial configuration, Licensors Pump will comprise both a MEMS Pump and a Pump Controller according to the Specifications.
Licensors Pump System is a system incorporating Licensor Pump including Pump Accessories.
Field of Use
The Field is all uses of an externally worn micro-pumps relating to the administration of insulin which insulin may be administered through a single pump, alone or in combination with other medications, such as glucagon and insulin.
IPSCIO Record ID: 280949
License Grant
A Swiss Licensor hereby grants to Licensee an exclusive, even as to Licensor, worldwide license, with the right to sublicense, under all Licensor Intellectual Property, excluding intellectual property jointly developed by Licensor and a third party, and a non-exclusive sub-license under Licensor Intellectual Property jointly developed by Licensor and a third party to make, have made, use, sell, offer for sale, or import Licensor Micro-Needle Products in the Field.
License Property
Licensed Patents all patents, patent applications and patent rights included in Licensor Intellectual Property, as well as patents, patent applications and patent rights resulting from joint inventions. A comprehensive list of such Licensed Patents, as of the Agreement Date, consists of a patent application filed in Sweden.
Licensor Micro-Needle one specific Licensor Micro-Needle Product to be developed by Licensor and Licensee under the Development Program pursuant to this Agreement, in accordance with the Micro-Needle Specifications.
Licensor Micro-Needle Products one or more families of micro-needle products, using MEMS Micro-Needle (the specifications of such Licensor Micro-Needle Products shall be mutually agreed by the parties).
Licensor Intellectual Property all patents, copyrights, trade secrets, know-how and other intellectual property related to or useful for a Micro-Needle based on MEMS technology owned by, developed by or licensed to Licensor, now or until such time as the license granted pursuant to this Agreement is terminated in accordance with this Agreement or becomes a fully paid-up license in accordance with of this Agreement (including, without limitation, the intellectual property described more specifically). Licensor Intellectual Property includes, without limitation, all ideas, methods, concepts, design features, diagrams, schematics, flowcharts, specifications, code (source and object) and any other intellectual property necessary or useful for Licensee to fully exercise its rights and perform its obligations under this Agreement or otherwise commercialize Licensor Micro-Needle Products in the Field. Notwithstanding the foregoing, Licensor Intellectual Property shall include intellectual property developed jointly by Licensor and a third party unless Licensor is prohibited by contractual agreement with such third party to license such intellectual property to another party.
MEMS Micro Electromechanical Systems using fabrication techniques similar to those utilized in the micro-electronics industry.
Micro-Needle any micro-needle device consisting of an array of micro-needles not exceeding 500 micron in depth.
Field of Use
Field All uses relating to the external administration of insulin, alone or in combination with other medications, and/or sensing of glucose.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
